Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

REGENERX BIOPHARMACEUTICALS INC (RGRX)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsDec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-31-17Dec-31-16Dec-31-15Dec-31-14
   10-K10-K10-K10-K10-K10-K10-K10-K
Revenues  0.10.10.10.10.10.10.10.0
            Revenue growth  0.0%0.0%10.2%23.0%-39.3%53.9% -100.0%
Cost of goods sold  0.00.00.00.00.00.00.00.0
Gross profit  0.10.10.10.10.10.10.10.0
            Gross margin  100.0%100.0%100.0%100.0%100.0%100.0%100.0% 
Selling, general and administrative   [+]1.41.41.31.31.41.51.61.2
Research and development  0.00.00.10.10.10.20.20.4
EBITDA   [+]  -1.3-1.3-1.4-1.7-1.7-1.6
            EBITDA margin  -1730.7%-1686.5%-1642.0%-1895.6%-2544.6%-1790.5%-2814.8% 
Depreciation and amortization    0.00.00.00.00.00.0
EBIT   [+]-1.3-1.3-1.3-1.3-1.4-1.7-1.7-1.6
            EBIT margin  -1730.7%-1686.5%-1643.9%-1899.6%-2550.0%-1794.1%-2820.5% 
Interest expense, net   [+]0.30.20.10.10.20.20.20.2
Other income (expense), net   [+]0.1  -0.62.02.1-3.4-1.0
Pre-tax income  -1.6-1.5-1.4-2.00.40.2-5.3-2.8
Income taxes  0.00.00.00.00.10.00.00.0
            Tax rate  0.0%0.0%0.0%0.0%25.6%0.0%0.0%0.0%
Net income  -1.6-1.5-1.5-2.00.30.2-5.3-2.8
            Net margin  -2081.5%-1984.6%-1936.9%-2861.5%505.7%245.6%-8695.4% 
   
Basic EPS   [+]($0.01)($0.01)($0.01)($0.02)$0.00$0.00($0.05)($0.03)
Diluted EPS   [+]($0.01)($0.01)($0.01)($0.02)$0.00$0.00($0.05)($0.03)
   
Shares outstanding (basic)   [+]138.6133.4131.0120.7107.4106.8101.593.2
Shares outstanding (diluted)   [+]138.6133.4131.0120.7120.9125.9101.593.2
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy